La cadena de opciones muestra datos clave de las opciones de acciones de Venus Concept a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Venus Concept..

Venus Concept (NASDAQ:VERO) Bolsa, Cadena de Opciones

Venus Concept

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

IGC Pharma

Pre-Market Outlook

PRGS

QMCO

VERO

XCUR

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: PRGS, XCUR, QMCO, VERO e IGC.

5 acciones en el foco en este premercado USA: PRGS, XCUR, QMCO, VERO e IGC

5 acciones en el foco este lunes: PRGS, XCUR, QMCO, VERO e IGC

Movimiento de acciones

News

Markets

Movers

Trading Ideas

AEHL

ASYS

EFXT

GNFT

HYFM

LFVN

MTUS

RSLS

RVSB

STSS

SUNE

VEEE

WHLR

ReShape Lifesciences firma acuerdo exclusivo con Motion Informatics y dispara sus acciones antes de la apertura de mercado.

Acciones de ReShape Lifesciences (RSLS) se disparan un 82%; Aquí están 20 acciones que se mueven en premercado

Venus Concept Inc

VERONI BRANDS CORP by Veroni Brands Corporation

Verona Pharma PLC ADR

Press Releases

Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stock

Earnings

Venus Concept Announces First Quarter 2025 Financial Results

Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million

Health Care

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Financing

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction

Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025

Venus Concept Announces Second Quarter 2025 Financial Results

Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025

Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction

Aethlon Medical

Autonomix Medical

Baird Medical Investment Holdings Ltd - Warrant

Baird Medical Investment

HeartBeam

Bluejay Diagnostics

Biomerica

Envoy Medical

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Alpha Tau Medical

GlucoTrack

HeartSciences

SeaStar Medical Holding Corporation - Warrant

SeaStar Medical Holding

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

INVO Fertility

Spectral AI

NanoVibronix

ENDRA Life Sciences

Nuwellis

Predictive Oncology

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Catheter Precision

Ladenburg Thalmann

Comments

Venus Concept

Venus Concept (VERO) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL